Clinical trial
The Study of the Early Administration of Alendronate on Prevention of Bone Loss…
NCT00346190 · McGill University Health Centre/Research Institute of the McGill University Health Centre, Other · Unknown status
Key facts
| NCT number | NCT00346190 |
|---|---|
| Title | The Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture. |
| Official title | A Six Month Double-Blind, Placebo-Controlled Trial Followed by Six Month Open-Label Study of the Early Administration of Alendronate on Prevention of Bone Loss After Hip Fracture. |
| Lead sponsor | McGill University Health Centre/Research Institute of the McGill University Health Centre, Other |
| Collaborators | Merck Frosst Canada Ltd. Industry |
| Status | Unknown status |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Osteoporosis |
| Intervention type | Drug |
| Interventions | Alendronate |
| Enrollment | 10 |
| Start date | Jan 1, 2003 |
| Completion | Apr 1, 2007 |
| First posted | Jun 29, 2006 |
| Last update posted | Apr 12, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: